The Immunopathophysiology of Multiple Sclerosis
- 31 May 2011
- journal article
- review article
- Published by Elsevier BV in Neurologic Clinics
- Vol. 29 (2), 257-278
- https://doi.org/10.1016/j.ncl.2010.12.009
Abstract
No abstract availableKeywords
This publication has 130 references indexed in Scilit:
- The blood–brain barrier, chemokines and multiple sclerosisBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011
- The role of antigen presenting cells in multiple sclerosisBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011
- T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experimental encephalomyelitisNature Medicine, 2010
- Antiviral immune responses: triggers of or triggered by autoimmunity?Nature Reviews Immunology, 2009
- Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluidAnnals of Neurology, 2009
- Cytokine mediators of Th17 functionEuropean Journal of Immunology, 2009
- Myeloid-derived suppressor cells as regulators of the immune systemNature Reviews Immunology, 2009
- Antigen specificity of clonally expanded and receptor edited cerebrospinal fluid B cells from patients with relapsing remitting MSJournal of Neuroimmunology, 2007
- Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patientsJournal of Neuroimmunology, 2006
- Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brainNature, 2003